x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Medical Device Global Market Access

Navigate every market. Accelerate every launch. Medical Device Global Market Access by Pure Global is the audio briefing that turns the world’s most confusing regulatory pathways into clear, actionable roadmaps. If you’re a MedTech founder, RA/QA leader, product manager, or investor who needs to get devices cleared anywhere from Austin to Abu Dhabi, this show is your shortcut. Why listen? • Step-by-step playbooks – We decode EU MDR, U.S. 510(k), Brazil’s ANVISA, China’s NMPA, and 25 + other

technology

All Episodes

03:14

From Code to Cash: A Guide to U.S. Medical Device...

Medical Device Global Market Access ·

2025/09/19

Securing a U.S. medical device code is only half the battle; the next challenge is determining its payment rate. This episode breaks down the three primary pathways for setting reimbursement rates in the United States. We explore the roles of CMS and private payers, detailing the specifics of the cross-walking and gap-filling processes, including key timelines like the annual summer public meetings. We also uncover the most common pitfalls that can delay or diminish your device's earning potential,

en

02:54

Beyond the Box: How Distributor Contracts Drive...

Medical Device Global Market Access ·

2025/09/18

Securing shelf space is just the beginning; ensuring your medical device is billable is the key to commercial success. This episode explores the crucial role a distributor plays in navigating the complex reimbursement landscape. We discuss how a strategic partner’s “contracting muscle” can manage interim billing codes, overcome Medicare edits, and leverage powerful GPO contracts to accelerate market adoption and ensure your innovation gets paid.Key Questions: • Why is a distributor’s reimbursement

en

03:18

FDA Import Readiness: U.S. Agent vs. Initial Importer...

Medical Device Global Market Access ·

2025/09/18

Navigating the FDA's import regulations requires a clear understanding of two critical, yet distinct, roles: the U.S. Agent and the Initial Importer. This episode breaks down their specific responsibilities, explaining how confusing them can lead to costly customs delays and compliance failures. We explore the specific regulatory burdens of the Initial Importer, including Medical Device Reporting and device listing, and highlight why manufacturers must verify their distributor’s capabilities to

en

03:04

MedTech's Last Mile: Ensuring Uptime with Superior...

Medical Device Global Market Access ·

2025/09/18

Beyond regulatory approval, the success of high-complexity medical devices hinges on a robust support infrastructure. This episode explores the critical, often-overlooked challenges of logistics, installation, and service. We delve into why cold-chain management, on-site validation, and 24/7 technical support are non-negotiable for devices like advanced analyzers and their sensitive consumables, particularly in meeting stringent lab requirements. Key Questions: • What are the hidden logistical

en

03:09

Beyond the Handshake: Structuring MedTech Distributor...

Medical Device Global Market Access ·

2025/09/17

Granting distributor exclusivity can be a powerful market entry tool, but it carries significant risks if not managed correctly. This episode explores how to structure robust distribution agreements by embedding specific Key Performance Indicators (KPIs) and strategic termination clauses to ensure accountability and protect your interests. We delve into the essential metrics and contractual safeguards that can make the difference between a thriving partnership and a costly mistake.• Is an

en

03:16

Unlock the US IVD Market: Finding the Right...

Medical Device Global Market Access ·

2025/09/16

Choosing the right U.S. distributor is a make-or-break decision for IVD manufacturers. This episode explores why customer fit and sales focus are more critical than size. We dissect the importance of matching a distributor’s call-points—be it hospital labs, reference labs, or physician offices—to your specific device and how to ensure your product becomes a priority for their sales team, rather than getting lost in a crowded catalog.• Why is a distributor's existing customer base the most

en

03:19

Cracking the Code: IVD Reimbursement in Europe vs....

Medical Device Global Market Access ·

2025/09/15

This episode breaks down the critical differences in securing reimbursement for In-Vitro Diagnostics (IVDs) between the European Union's national HTA bodies and the payer-driven system in the United States. We explore the specific requirements of key European agencies like Germany's G-BA and France's HAS and contrast them with the evidence demanded by CMS and private insurers in the U.S. Key Questions: • Is there a single reimbursement pathway for an IVD in the European Union? • Which national

en

03:19

Unlocking U.S. Medicare Coverage for Your IVD Test

Medical Device Global Market Access ·

2025/09/14

This episode breaks down the complex process of how the U.S. Centers for Medicare & Medicaid Services (CMS) decides whether to cover a new in-vitro diagnostic (IVD) test. We explore the critical "reasonable and necessary" standard, the difference between National and Local Coverage Determinations, and the vital role of clinical utility evidence in securing a positive decision. Learn about the specific frameworks CMS uses and the specialized programs in place for advanced diagnostics.Key

en

03:26

IVD Pricing Power: The Post-Market Data Payers Demand

Medical Device Global Market Access ·

2025/09/13

This episode delves into the critical post-market data strategies required to secure and defend reimbursement for innovative in-vitro diagnostics (IVDs). We explore the distinct evidence that persuades U.S. insurers versus EU payers, moving beyond initial regulatory approval to focus on long-term value demonstration. Learn about the types of real-world evidence, registry studies, and economic data that are most effective for renegotiating coverage and justifying premium pricing in these key global

en

03:40

Securing Your Assay's CPT Code: A Guide to US...

Medical Device Global Market Access ·

2025/09/12

This episode details the process of obtaining a unique CPT or PLA code for a diagnostic assay in the U.S. and its direct impact on reimbursement under the Medicare Clinical Laboratory Fee Schedule (CLFS). We cover the application steps with the American Medical Association (AMA), the role of the PAMA Act, and recent legislative updates affecting payment rates and reporting deadlines.• What is a Proprietary Laboratory Analyses (PLA) code and why is it crucial for my new assay? • What is the

en

03:15

FDA Export Certificates: Navigating Apostille and...

Medical Device Global Market Access ·

2025/09/11

This episode demystifies the critical process of authenticating FDA export documents, such as the Certificate to Foreign Government (FSC/CFG), for international markets. We explore the difference between an apostille and full legalization, explain why foreign regulators require this step, and detail the impact of the FDA's transition to electronic certificates as of January 2, 2024. Learn the new rules and procedures to ensure your medical device shipments aren't delayed at the border.Key

en

03:26

Unlocking Exports: FSC Documentation by Device Class

Medical Device Global Market Access ·

2025/09/10

This episode provides a detailed guide on the essential supporting documents required for a Free Sales Certificate (FSC) application. We break down the specific requirements based on medical device classification under the EU MDR, clarifying which documents, such as the Declaration of Conformity, ISO 13485, and CE certificates, are necessary for Class I, IIa, IIb, and III devices. Understand the critical differences in documentation to ensure your export applications are successful.Key

en

03:38

Your Product's Passport: Unlocking Global Sales with...

Medical Device Global Market Access ·

2025/09/09

In this episode, we demystify the Free Sales Certificate (FSC), a critical document for medical device and IVD manufacturers aiming for international expansion. We explore what an FSC is, why it's a mandatory requirement for registration in many countries across Asia, Latin America, and the Middle East, and how it serves as proof of regulatory compliance in your home market. The host explains who issues these certificates in key regions like the EU and the US, and discusses recent changes under the

en

02:55

Navigating FDA Export Certificates: Timelines, Fees,...

Medical Device Global Market Access ·

2025/09/08

This episode demystifies the process of obtaining a Certificate to Foreign Government (CFG), also known as a Free Sale Certificate (FSC), from the US FDA. We cover the official timelines for issuance, the specific government fees you can expect to pay, and the critical procedural shift to electronic-only certificates that took effect in early 2024. Learn the essential details to plan your international market submissions effectively and avoid costly delays. • What is the official FDA term for a

en

03:20

Certificate of Free Sale: Who Is Eligible to Apply?

Medical Device Global Market Access ·

2025/09/08

This episode clarifies the complex eligibility requirements for obtaining a Certificate of Free Sale (FSC) for medical device exports. We dissect the critical differences between the regulatory frameworks in the United States and the European Union, explaining precisely who—from manufacturer to exporter to authorized representative—can legally apply for this essential market access document in each region. Key Questions: • What is a Certificate of Free Sale (FSC) and why do exporters need it? • In

en

03:05

Unlocking the FDA 510(k) with Your Japanese PMDA...

Medical Device Global Market Access ·

2025/09/07

Many companies believe that getting medical device approval in Japan might fast-track their entry into the U.S. market. This episode breaks down that misconception and reveals the strategic pathway that actually exists. We explore how the FDA’s Abbreviated 510(k) program allows manufacturers to leverage their existing PMDA data, focusing on the crucial role of internationally recognized consensus standards. Learn how this approach can save significant time and resources compared to a traditional

en

03:52

From China to Brazil: Navigating ANVISA without NMPA...

Medical Device Global Market Access ·

2025/09/06

This episode clarifies whether a medical device approved by China's NMPA can benefit from an expedited registration process with Brazil's ANVISA. We detail the full Brazilian regulatory requirements, including classification, the role of a Brazil Registration Holder (BRH), B-GMP certification, and the AREE program, explaining why NMPA approval doesn't currently offer a shortcut. • Can my Chinese NMPA approval speed up device registration in Brazil? • What is the AREE program, and which countries

en

03:44

From Brazil to the US: Unpacking ANVISA and FDA...

Medical Device Global Market Access ·

2025/09/05

This episode tackles a common question from MedTech manufacturers: can a successful ANVISA registration in Brazil streamline the path to FDA 510(k) clearance in the United States? We explore the reality of regulatory reliance between these two key markets, clarifying the one-way nature of current frameworks and outlining how your existing ANVISA technical documentation can still provide a significant advantage for your US submission.• Does the FDA recognize or have a reliance pathway for

en

03:55

From NMPA to CE Mark: Bridging the Regulatory Gap

Medical Device Global Market Access ·

2025/09/04

This episode breaks down the essential differences between China's NMPA approval and the EU's rigorous MDR CE marking process. We explore the key gaps in regulatory philosophy, clinical data requirements, and post-market surveillance that manufacturers must bridge to expand from the Chinese to the European market.Key Questions: • Is my NMPA approval enough to get a CE mark in Europe? • What is the difference between a Notified Body and the NMPA? • How do EU MDR requirements for a Clinical

en

04:33

From NMPA to FDA: Leveraging China Approval for U.S....

Medical Device Global Market Access ·

2025/09/03

This episode details the process for medical device manufacturers to obtain FDA 510(k) clearance in the United States after securing Class III approval from China's NMPA. We explain that there is no direct reciprocity and outline how to strategically leverage existing Chinese technical documentation, clinical data, and testing reports. The focus is on conducting a thorough gap analysis to meet the FDA's unique requirements, particularly the concept of "substantial equivalence" to a predicate device

en

329 results

Similar Podcasts

Lead With AI

Tamara Nall

Linux in the Ham Shack

Black Sparrow Media

Data Engineering Podcast

Tobias Macey

Eye On A.I.

Craig S. Smith

Reflections

Livewire Labs